跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REMAFEN TABLET 25 mg - HSA Drug Approval Details
Approvals
/
HSA
/
REMAFEN TABLET 25 mg
Approved
THERAPEUTIC
REMAFEN TABLET 25 mg
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
May 27, 1991
Approval ID
f8bddbe630547e09
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
f8bddbe630547e09
Drug Name
REMAFEN TABLET 25 mg
Product Name
REMAFEN TABLET 25 mg
Approval Number
SIN05990P
Approval Date
1991-05-27
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
ENTERIC COATED TABLET
Route Of Administration
ORAL
Atc Code
M01AB05
Atc Item Name
diclofenac
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
DICLOFENAC SODIUM
25 mg
DICLOFENAC SODIUM
25 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 27, 1991
Approval ID
f8bddbe630547e09
Type
Therapeutic
Back to HSA Approvals